monoclonal antibody RAV12
Term · Oncology and biomedicine · MLC-T-ONC-015274
A chimeric monoclonal antibody directed against a primate-restricted N-linked carbohydrate epitope (glycotope) expressed on various human carcinomas with potential antineoplastic activity. Following binding, monoclonal antibody RAV12 disrupts sodium channels of tumor cells expressing this glycotope, resulting in cell and organelle swelling, loss of membrane integrity, and cell death.
| Identifier | MLC-T-ONC-015274 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | anti-RAAG12 MOAB |
| Synonyms | RAV12; anti-RAAG12 monoclonal antibody |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015274",
"term": "monoclonal antibody RAV12",
"field": "Oncology and biomedicine",
"definition": "A chimeric monoclonal antibody directed against a primate-restricted N-linked carbohydrate epitope (glycotope) expressed on various human carcinomas with potential antineoplastic activity. Following binding, monoclonal antibody RAV12 disrupts sodium channels of tumor cells expressing this glycotope, resulting in cell and organelle swelling, loss of membrane integrity, and cell death.",
"abbreviation": "anti-RAAG12 MOAB",
"synonyms": [
"RAV12",
"anti-RAAG12 monoclonal antibody"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/monoclonal-antibody-rav12/"
}
Record 11,254 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.